Order Article Reprints

Tanaka M, Miura H, Ishimaru S, Furukawa G, Kawamura Y, Kozawa K, Yamada S, Ito F, Kudo K, Yoshikawa T. Future Perspective for ALK-Positive Anaplastic Large Cell Lymphoma with Initial Central Nervous System (CNS) Involvement: Could Next-Generation ALK Inhibitors Replace Brain Radiotherapy for the Prevention of Further CNS Relapse? Pediatric Reports. 2023; 15(2):333-340. https://doi.org/10.3390/pediatric15020029

Tanaka, Makito, Hiroki Miura, Soichiro Ishimaru, Gen Furukawa, Yoshiki Kawamura, Kei Kozawa, Seiji Yamada, Fumitaka Ito, Kazuko Kudo, and Tetsushi Yoshikawa. 2023. "Future Perspective for ALK-Positive Anaplastic Large Cell Lymphoma with Initial Central Nervous System (CNS) Involvement: Could Next-Generation ALK Inhibitors Replace Brain Radiotherapy for the Prevention of Further CNS Relapse?" Pediatric Reports 15, no. 2: 333-340. https://doi.org/10.3390/pediatric15020029

Tanaka, M., Miura, H., Ishimaru, S., Furukawa, G., Kawamura, Y., Kozawa, K., Yamada, S., Ito, F., Kudo, K., & Yoshikawa, T. (2023). Future Perspective for ALK-Positive Anaplastic Large Cell Lymphoma with Initial Central Nervous System (CNS) Involvement: Could Next-Generation ALK Inhibitors Replace Brain Radiotherapy for the Prevention of Further CNS Relapse? Pediatric Reports, 15(2), 333-340. https://doi.org/10.3390/pediatric15020029